Windlas Biotech Limited (BOM:543329)
India · Delayed Price · Currency is INR 993.25
+7.95 (0.81%)
At close: Aug 21, 2026
Windlas Biotech Market Cap
Windlas Biotech has a market cap or net worth of 20.5 billion as of August 21, 2026. Its market cap has decreased by -4.39% in one year.
Market Cap
20.50B
Enterprise Value
18.07B
Revenue
9.42B
Ranking
n/a
PE Ratio
30.86
Stock Price
993.25
ChartMarket Cap Chart
Since August 16, 2021, Windlas Biotech's market cap has increased from 8.87B to 20.50B, an increase of 131.07%. That is a compound annual growth rate of 18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 20.50B | 23.05% |
| Dec 31, 2025 | 16.66B | -23.42% |
| Dec 31, 2024 | 21.76B | 144.02% |
| Dec 29, 2023 | 8.92B | 66.28% |
| Dec 30, 2022 | 5.36B | -10.83% |
| Dec 31, 2021 | 6.01B | -32.22% |
| Aug 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novartis India | 35.14B |
| Kwality Pharmaceuticals | 34.83B |
| Hikal | 26.67B |
| Fredun Pharmaceuticals | 23.73B |
| Venus Remedies | 23.13B |
| Shukra Pharmaceuticals | 19.39B |
| Amrutanjan Health Care | 15.51B |
| TTK Healthcare | 15.46B |